The Observer (Kampala)

Uganda: Ssekandi Visits ARVs Plant, to Lobby EAC

Vice President Edward Kiwanuka Ssekandi this week pledged to lobby East African countries to purchase Ugandan-made antiretroviral drugs.

Speaking at the end of his two-hour visit to the Luzira-based Quality Chemical Industries, Kiwanuka was surprised at the nature of technology in use at the plant.

"This isn't what I had in mind. This is technology for a developed country, not a developing country like Uganda." Ssekandi said.

The factory owners say the plant has helped reduce the number of Ugandans dying of malaria daily from 400 to 200 - while increasing ARV access to 500,000 Ugandans.

"That has been our biggest contribution to changing lives in Uganda. Our target should be zero," said Emmanuel Katongole, the Chief Executive Officer of Quality Chemical Industries.

Katongole asked Ssekandi to encourage the government to participate in QCIL's plans to start a second plant. The company also plans to start producing a single ARV tablet to ease patients' intake of the drugs. QCIL has already signed up trade partnerships with the Kenya and Rwanda governments, with South Sudan and DR Congo the next targets.

Ads by Google

Copyright © 2012 The Observer. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 2,000 reports a day from more than 130 news organizations and over 200 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.